Dynapenia and sarcopenia: association with the diagnosis, duration and complication of type 2 diabetes mellitus in ELSA-Brasil

Nenhuma Miniatura disponível
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
DOI
Scopus
Web of Science
PubMed
Dimensions
Título da Revista
ISSN da Revista
Título do Volume
Editora
CADERNOS SAUDE PUBLICA
Autores
SANTOS, Debora Noara Duarte dos
COELHO, Carolina Gomes
DINIZ, Maria de Fatima Haueisen Sander
DUNCAN, Bruce Bartholow
SCHMIDT, Maria Ines
SZLEJF, Claudia
TELLES, Rosa Weiss
BARRETO, Sandhi Maria
Citação
CADERNOS DE SAUDE PUBLICA, v.40, n.1, article ID e00081223, 19p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Sarcopenia (the loss of muscle mass, strength and skeletal muscle function) increases mortality and the risk of hospitalization in the older population. Although it is known that older adults with type 2 diabetes mellitus (T2DM) have a higher risk of dynapenia and sarcopenia, few studies have investigated these conditions in middle-aged populations. The objective of this study was to investigate whether T2DM, its duration, the presence of albuminuria, and glycemic control are associated with sarcopenia and its components in adults. The cross-sectional analysis was based on data from visit 2 of the Brazilian Longitudinal Study of Adult Health (2012-2014 ). The 2018 European Working Group on Sarcopenia in Older People criteria were used to define dynapenia, low appendicular muscle mass (LAMM), and sarcopenia (absent/ probable/confirmed). The explanatory variables were: T2DM; duration of T2DM; T2DM according to the presence of albuminuria; and glycemic control (HbA1C < 7%) among people with T2DM. A total of 12,132 participants (mean age = 55.5, SD: 8.9 years) were included. The odds ratio for LAMM was greater among those with T2DM, T2DM duration from 5 to 10 years, and T2DM without albuminuria. Chances of dynapenia were higher among those with T2DM, T2DM duration > 10 years, and T2DM with and without albuminuria. The variables T2DM, T2DM >= 10 years, and T2DM with albuminuria increased the odds of probable sarcopenia, and T2DM duration from 5 to 10 years increased the odds of confirmed sarcopenia. The results support the importance of frequently monitoring the musculoskeletal mass and strength of individuals with T2DM to prevent sarcopenia and related outcomes.
Palavras-chave
Sarcopenia, Hand Grip Strength, Muscle Strength, Type 2 Diabetes Mellitus
URI
https://observatorio.fm.usp.br/handle/OPI/58786
Referências
  1. Ai YQ, 2021, DIABETOL METAB SYNDR, V13, DOI 10.1186/s13098-021-00707-7
  2. Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS135, DOI 10.2337/dc20-s011
  3. Amer Diabet Assoc, 2020, DIABETES CARE, V43, pS66, DOI 10.2337/dc20-S006
  4. [Anonymous], GUIDELINES DATA PROC
  5. Aquino EML, 2012, AM J EPIDEMIOL, V175, P315, DOI 10.1093/aje/kwr294
  6. Barreto SM, 2016, J EPIDEMIOL COMMUN H, V70, P380, DOI 10.1136/jech-2015-205834
  7. Barreto SM, 2013, REV SAUDE PUBL, V47, P79, DOI 10.1590/S0034-8910.2013047003836
  8. Benjumea Angela-Maria, 2018, Open Access Maced J Med Sci, V6, P344, DOI 10.3889/oamjms.2018.087
  9. Bertoni M, 2018, EXP GERONTOL, V108, P87, DOI 10.1016/j.exger.2018.04.001
  10. Borges VS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311x00107319, 10.1590/0102-311X00107319]
  11. Bouchi R, 2017, J DIABETES INVEST, V8, P783, DOI 10.1111/jdi.12636
  12. Buckinx F, 2018, J CACHEXIA SARCOPENI, V9, P269, DOI 10.1002/jcsm.12268
  13. Cesari M, 2009, J AM GERIATR SOC, V57, P251, DOI 10.1111/j.1532-5415.2008.02126.x
  14. Chung HS, 2018, J GERONTOL A-BIOL, V73, P386, DOI 10.1093/gerona/glx055
  15. Coppini LZ, 2005, CURR OPIN CLIN NUTR, V8, P329, DOI 10.1097/01.mco.0000165013.54696.64
  16. Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169
  17. Cruz-Jentoft AJ, 2014, AGE AGEING, V43, P748, DOI 10.1093/ageing/afu115
  18. Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034
  19. Cui MZ, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000018708
  20. Fang WH, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000019103
  21. Fedeli LG, 2013, REV SAUDE PUBL, V47, P63, DOI 10.1590/S0034-8910.2013047003807
  22. Fuggle N, 2017, BEST PRACT RES CL RH, V31, P218, DOI 10.1016/j.berh.2017.11.007
  23. Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x
  24. Guerrero N, 2016, DIABETES RES CLIN PR, V117, P32, DOI 10.1016/j.diabres.2016.04.011
  25. He QH, 2020, J DIABETES RES, V2020, DOI 10.1155/2020/6973469
  26. Kim M, 2015, GERIATR GERONTOL INT, V15, P1013, DOI 10.1111/ggi.12384
  27. Laiteerapong N, 2019, DIABETES CARE, V42, P416, DOI 10.2337/dc17-1144
  28. Diz JBM, 2017, GERIATR GERONTOL INT, V17, P5, DOI 10.1111/ggi.12720
  29. Mesinovic J, 2019, DIABET METAB SYND OB, V12, P1057, DOI 10.2147/DMSO.S186600
  30. Mori H, 2019, DIABETOL INT, V10, P183, DOI 10.1007/s13340-019-00400-1
  31. Mori H, 2019, J DIABETES INVEST, V10, P1332, DOI 10.1111/jdi.13014
  32. Morley JE, 2014, J CACHEXIA SARCOPENI, V5, P253, DOI 10.1007/s13539-014-0161-y
  33. Nebuloni CC, 2020, J GERONTOL A-BIOL, V75, P1191, DOI 10.1093/gerona/glz257
  34. Park SW, 2006, DIABETES, V55, P1813, DOI 10.2337/db05-1183
  35. Pechmann LM, 2020, INT J ENDOCRINOL, V2020, DOI 10.1155/2020/7841390
  36. Peterson MD, 2016, J AM MED DIR ASSOC, V17, P933, DOI 10.1016/j.jamda.2016.06.007
  37. ROSENBERG IH, 1989, AM J CLIN NUTR, V50, P1231, DOI 10.1093/ajcn/50.5.1231
  38. Santilli V, 2014, CLIN CASES MINER BON, V11, P177, DOI 10.11138/ccmbm/2014.11.3.177
  39. Schmidt MI, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-123
  40. Sociedade Brasileira de Diabetes, Diretrizes da Sociedade Brasileira de Diabetes 2019-2020
  41. Sousa-Santos AR, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0625-y
  42. Su Y, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030291
  43. Sugimoto K, 2019, J DIABETES INVEST, V10, P1471, DOI 10.1111/jdi.13070
  44. Trierweiler H, 2018, DIABETOL METAB SYNDR, V10, DOI 10.1186/s13098-018-0326-5
  45. Vergara Ruiz José Carlos, 2017, Rev Clin Med Fam, V10, P86
  46. Wang TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep38937
  47. Wilkinson TJ, 2021, J CACHEXIA SARCOPENI, V12, P586, DOI 10.1002/jcsm.12705
  48. Yoon JW, 2016, DIABETES METAB J, V40, P140, DOI 10.4093/dmj.2016.40.2.140
  49. Yu SCY, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040189
  50. Zoungas S, 2014, DIABETOLOGIA, V57, P2465, DOI 10.1007/s00125-014-3369-7

Coleções
Artigos e Materiais de Revistas Científicas - FM/MCM